2023-03-30T16:58:21+08:00 weekly 1.0 https://ko.prisysbiotech.com/ 2024-11-13T02:25:00+08:00 weekly 0.9 https://ko.prisysbiotech.com/ophthalmic-disease-research 2024-11-13T02:24:47+08:00 weekly 0.9 https://ko.prisysbiotech.com/animal-welfare 2024-11-13T02:24:51+08:00 weekly 0.9 https://ko.prisysbiotech.com/hematological-disease-research 2024-11-13T02:24:56+08:00 weekly 0.9 https://ko.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-13T02:24:55+08:00 weekly 0.9 https://ko.prisysbiotech.com/metabolic-syndromes-research 2023-03-31T10:52:57+08:00 weekly 0.9 https://ko.prisysbiotech.com/co-develop 2024-11-13T02:24:55+08:00 weekly 0.9 https://ko.prisysbiotech.com/respiratory-disease-research 2024-11-13T02:24:45+08:00 weekly 0.9 https://ko.prisysbiotech.com/translational-research-center 2024-11-13T02:24:52+08:00 weekly 0.9 https://ko.prisysbiotech.com/inflammation-immunology-disorders 2024-11-13T02:24:44+08:00 weekly 0.9 https://ko.prisysbiotech.com/download 2024-09-29T14:45:25+08:00 weekly 0.9 https://ko.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://ko.prisysbiotech.com/fibrosis 2024-11-13T02:24:46+08:00 weekly 0.9 https://ko.prisysbiotech.com/about-us 2024-11-13T02:24:44+08:00 weekly 0.9 https://ko.prisysbiotech.com/contact-us 2023-03-31T10:52:52+08:00 weekly 0.9 https://ko.prisysbiotech.com/newslist-1 2024-11-13T02:24:49+08:00 weekly 0.9 https://ko.prisysbiotech.com/products 2026-02-07T02:37:28+08:00 weekly 0.9 https://ko.prisysbiotech.com/blog/ 2023-03-31T10:33:30+08:00 weekly 0.9 https://ko.prisysbiotech.com/translation-research/ 2023-03-31T10:33:30+08:00 weekly 0.9 https://ko.prisysbiotech.com/safety-evaluation/ 2023-03-31T10:33:30+08:00 weekly 1.0 https://ko.prisysbiotech.com/nhp-pharmacology/ 2023-03-31T10:33:30+08:00 weekly 0.9 https://ko.prisysbiotech.com/pk-pd-adme/ 2023-03-31T10:33:31+08:00 weekly 0.9 https://ko.prisysbiotech.com/biosafety-research/ 2024-04-10T12:48:46+08:00 weekly 0.9 https://ko.prisysbiotech.com/clearpoint/ 2023-03-31T10:52:41+08:00 weekly 0.8 https://ko.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-13T02:24:43+08:00 weekly 0.8 https://ko.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2023-03-31T10:52:40+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2023-03-31T10:52:43+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2023-03-31T10:52:46+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2024-11-13T02:24:48+08:00 weekly 0.8 https://ko.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-11-13T02:24:44+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-13T02:24:44+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2023-03-31T10:52:43+08:00 weekly 0.8 https://ko.prisysbiotech.com/safety-evaluation/toxicology.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ko.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-13T02:24:47+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-13T02:24:47+08:00 weekly 0.8 https://ko.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-13T02:51:08+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-11-13T02:24:47+08:00 weekly 0.8 https://ko.prisysbiotech.com/translation-research/nhpresources.html 2023-03-31T10:52:52+08:00 weekly 0.8 https://ko.prisysbiotech.com/translation-research/translational-studies.html 2023-03-31T10:52:47+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-13T02:24:43+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2024-11-13T02:24:48+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-03-31T10:52:52+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-03-31T10:52:46+08:00 weekly 0.8 https://ko.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2023-03-31T10:52:46+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2023-03-31T10:52:46+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-13T02:24:45+08:00 weekly 0.8 https://ko.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-03-31T10:52:45+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-13T02:24:49+08:00 weekly 0.8 https://ko.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2023-03-31T10:52:46+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2024-11-13T02:24:47+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-31T10:52:52+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-03-31T10:52:46+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-13T02:24:41+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2024-11-13T02:24:49+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-13T02:24:45+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2023-03-31T10:52:52+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2023-03-31T10:52:46+08:00 weekly 0.8 https://ko.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-13T02:24:49+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-13T02:24:45+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-13T02:25:30+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2024-11-13T02:24:53+08:00 weekly 0.8 https://ko.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-13T02:25:04+08:00 weekly 0.8 https://ko.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-13T02:24:53+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-13T02:25:16+08:00 weekly 0.8 https://ko.prisysbiotech.com/translation-research/clinical-imaging.html 2024-11-13T02:25:08+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-26T14:17:41+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-26T14:17:41+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-09-26T14:17:47+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-09-26T14:21:09+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-26T14:22:03+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-26T14:47:04+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-12-04T13:43:00+08:00 weekly 0.8 https://ko.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2024-12-04T13:43:18+08:00 weekly 0.8 https://ko.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2025-04-02T03:03:03+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-04-02T03:03:16+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-07-12T20:49:29+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-12T20:49:40+08:00 weekly 0.8 https://ko.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-20T01:10:36+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-13T18:30:33+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-20T05:07:31+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-24T23:08:46+08:00 weekly 0.8 https://ko.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-09-29T16:06:03+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T12:08:10+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T18:41:39+08:00 weekly 0.8 https://ko.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2023-03-31T10:33:29+08:00 weekly 0.9 https://ko.prisysbiotech.com/newslist-713610-1 2023-03-31T10:52:43+08:00 weekly 0.9 https://ko.prisysbiotech.com/newslist-713611-1 2024-07-29T16:33:03+08:00 weekly 0.9 https://ko.prisysbiotech.com/newslist-818684-1 2023-03-31T10:52:39+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/meetprisys-sot2023-66085948.html 2023-03-31T10:52:39+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66085949.html 2023-03-31T10:52:41+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66085950.html 2023-03-31T10:52:40+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-sot2023-66085951.html 2023-03-31T10:52:41+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/gene-therapy-nhp-model-66085952.html 2023-03-31T10:52:46+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66085953.html 2023-03-31T10:52:40+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66085954.html 2023-03-31T10:52:44+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66085955.html 2023-03-31T10:52:44+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66085956.html 2023-03-31T10:52:51+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66085958.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/gene-therapy-toxicology-66267855.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67241274.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67241275.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67241278.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67241280.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67241281.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67241283.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67241289.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/world-parkinsons-disease-day-67241292.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68103153.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68103155.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68103162.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68103176.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68307119.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-68995858.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-68996678.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-68996921.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-68997274.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-68999195.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69002992.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309283.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309315.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309329.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309416.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69653975.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69658656.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/0-70941438.html 2025-07-23T10:06:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-70941439.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-70941441.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-70941442.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-70941444.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-70941445.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72321257.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72321258.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72321259.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72321260.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72321261.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72674337.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73001109.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73526822.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73526823.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74124187.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74654612.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74782971.html 2024-11-13T02:24:53+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75160853.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75160854.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76173649.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77052010.html 2024-11-13T02:24:48+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77698555.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77698562.html 2024-11-13T02:25:04+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79189922.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-asthma-model-79189923.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79189927.html 2024-11-13T02:24:49+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79189928.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79189932.html 2024-11-13T02:24:49+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79410712.html 2024-11-13T02:24:51+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79410713.html 2024-11-13T02:25:01+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79410714.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79528468.html 2024-11-13T02:24:47+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79528470.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79528478.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79528479.html 2024-11-13T02:24:50+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pk-strategies-of-pdc-79528481.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79528482.html 2024-11-13T02:24:54+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79528483.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79528484.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79528485.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79528486.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79528487.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79528488.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79528490.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79528491.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79528492.html 2024-11-13T02:24:49+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79528494.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79528496.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79528497.html 2024-11-13T02:24:48+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79528498.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79528499.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79528500.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79528501.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79528502.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79528503.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79528504.html 2024-11-13T02:24:48+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/mrna-based-therapies-past-79528505.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79528506.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79528507.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79528508.html 2024-11-13T02:24:58+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79528509.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79528511.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79528512.html 2024-11-13T02:24:49+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79528514.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79528515.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79528516.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79528517.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79528518.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79528519.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79528520.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79528521.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79528522.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/mrna-based-therapies-present-79528524.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79528525.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/significance-principles-and-requirements-of-79528527.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79528528.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79528529.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79528530.html 2024-08-07T08:44:33+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656480.html 2024-11-13T02:24:54+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/convection-enhanced-delivery-81120622.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81120623.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81120624.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/china-experimental-monkey-industry-81120625.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/animal-models-of-human-diseases-81120626.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81120627.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/human-disease-animal-models-81120628.html 2024-11-13T02:24:56+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81120629.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81120630.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81120632.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/compartment-pk-model-81120634.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81121022.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81121024.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82378344.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82653680.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82653681.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82653682.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82653683.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82653684.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82653686.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82653687.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82653689.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82653935.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-82980981.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-82981998.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-82981999.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-84008650.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-84008651.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-84008652.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-84008653.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-84008668.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-84008695.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-84008696.html 2025-01-19T10:58:27+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-84008731.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-84009449.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17244150502597632.html 2025-02-27T03:28:53+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17244188654953472.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295707093591040.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295707105747968.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295707132339200.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/animal-models-for-womens-health-17295707178886144.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/membranous-nephropathy-model-17295707180114944.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295707206558720.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295707208393728.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295707222156288.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295707263116288.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295707284120576.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295707292738560.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17295707364500480.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295707391714304.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295707499832320.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295707527144448.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295740619088896.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295740868862976.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17299861299504128.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374322273379328.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374322292499456.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374322294875136.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374322363360256.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374322364130304.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374322372355072.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374322393310208.html 2025-05-27T15:55:04+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374322425553920.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374322468709376.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374322686157824.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374322793096192.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17380901333640192.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17439728783778816.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17439728835322880.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17439728844153856.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17439728931628032.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/key-considerations-for-dosing-volume-17439728966198272.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17439728973407232.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17439729019905024.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17439729136067584.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17439729138197504.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17439729263944704.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17439729492960256.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17439729892942848.html 2025-08-20T01:10:39+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17493754792797184.html 2025-08-20T01:10:27+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17493754802840576.html 2025-08-20T01:10:23+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17493754837001216.html 2025-08-20T01:10:28+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17493754925851648.html 2025-08-20T01:10:23+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-copd-model-17493754930226176.html 2025-08-20T01:10:27+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17493755332649984.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/brain-targeted-drug-delivery-17528773587182592.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17528773629912064.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/the-importance-of-administration-volume-17528773681800192.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17528773726905344.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17528773734048768.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17528773771584512.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17528773786231808.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17537893250065408.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17551281158661120.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17625014755779584.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17625014787957760.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17625014827787264.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17625014896944128.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17625014950732800.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/rfp-template-for-nhp-studies-17625014970688512.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17625014979945472.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17625015095714816.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-renal-biopsy-17625015295353856.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17625015360676864.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17625016356676608.html 2025-12-25T12:08:38+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674181327381504.html 2025-12-25T12:07:54+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674181337261056.html 2025-12-25T12:08:34+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674181401928704.html 2025-12-25T12:08:05+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674181413168128.html 2025-12-25T12:08:04+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674181461763072.html 2025-12-25T12:08:05+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674181525595136.html 2025-12-25T12:08:07+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674181544109056.html 2025-12-25T12:08:05+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674181545993216.html 2025-12-25T12:08:18+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674181784921088.html 2026-01-29T18:42:03+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724117255054336.html 2026-01-29T18:41:46+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724117255857152.html 2026-03-27T17:38:42+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724117268407296.html 2026-01-29T18:41:35+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724117342495744.html 2026-01-29T18:41:37+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724117494309888.html 2026-01-29T18:41:40+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724117517394944.html 2026-01-29T18:41:38+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724117519950848.html 2026-01-29T18:41:40+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724117578114048.html 2026-01-29T18:41:45+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724117598512128.html 2026-01-29T18:42:20+08:00 weekly 0.8 https://ko.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724117674206208.html 2026-02-06T06:16:55+08:00 weekly 0.8 https://ko.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-12T04:51:27+08:00 weekly 0.8 https://ko.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-02-27T06:19:51+08:00 weekly 0.8 https://ko.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html 2026-03-03T06:29:07+08:00 weekly 0.8 https://ko.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html 2026-03-10T06:10:54+08:00 weekly 0.8 https://ko.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-24T05:34:31+08:00 weekly 0.8 https://ko.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html